Market Tracker

07/24 5:16pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

55.02
Delayed Data
As of Jul 24
 +0.63 / +1.16%
Today’s Change
42.58
Today|||52-Week Range
75.36
+4.26%
Year-to-Date

Today’s Trading

Previous close54.39
Today’s open54.53
Day’s range54.13 - 55.13
Volume878,550
Average volume (3 months)954,641
Market cap$7.8B
Dividend yield--
Data as of 3:59pm ET, 07/24/2017

Growth & Valuation

Earnings growth (last year)-7.53%
Earnings growth (this year)-66.64%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+24.15%
P/E ratioNM
Price/Sales17.76
Price/Book12.20

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.52+1.85%
TSROTESARO Inc-2.10-1.59%
RDYDr.Reddy's Laborator...-0.94-2.21%
IONSIonis Pharmaceutical...+3.17+5.62%
Data as of 4:02pm ET, 07/24/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$418.1M
Annual profit (last year)-$140.1M
Net profit margin-33.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts